![Krishna Vaddi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Krishna Vaddi
Founder at
PRELUDE THERAPEUTICS INCORPORATED
Net worth: 14 M $ as of 2026-05-30
Profile
Dr. Krishna Vaddi is a Chief Executive Officer & Director at Prelude Therapeutics, Inc. He is on the Board of Directors at Prelude Therapeutics, Inc. Dr. Vaddi was previously employed as a Chief Executive Officer by Orsenix LLC and an Executive Director & Group Vice President by Incyte Corp. He received his undergraduate degree from Acharya N. G. Ranga Agricultural University and a doctorate degree from the University of Florida.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-26 | 3,669,054 ( 5.65% ) | 14 M $ | 2026-05-30 |
Krishna Vaddi active positions
| Companies | Position | Start |
|---|---|---|
| PRELUDE THERAPEUTICS INCORPORATED | Founder | 2015-12-31 |
Former positions of Krishna Vaddi
| Companies | Position | End |
|---|---|---|
Orsenix LLC | Chief Executive Officer | 2016-05-31 |
| INCYTE CORPORATION | Director/Board Member | 2015-05-31 |
Training of Krishna Vaddi
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
46
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Incyte Corp.
 Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
University of Florida
 University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acharya N. G. Ranga Agricultural University
 Acharya N. G. Ranga Agricultural University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prelude Therapeutics, Inc.
 Prelude Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines targeting chromatin function to treat cancer and rare diseases | Health Technology |
Orsenix LLC |
- Stock Market
- Insiders
- Krishna Vaddi
